Role of Pet/Ct in Assessment of Post Therapeutic Hepatocellular Carcinoma | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 16, Volume 69, Issue 4, October 2017, Page 2271-2277 PDF (695.26 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.12816/0041529 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Omar Hussain Omar; Mohamed Elgharib Abo Elmaaty; Ayman Mohamed Ibrahim; Sherif Sameh Soliman* | ||||
| Radiodiagnosis Department, Ain Shams University, Cairo, Egypt | ||||
| Abstract | ||||
| Aim of the work: this study aimed to highlight the role of PET/CT in evaluation of post-therapeutic hepatocellular carcinoma, hence guiding the clinician to proper management strategy. Patients and methods: 35 patients (32 male and 3 female) were included in this study. All patients had history of local treatment of HCC; most of the cases were treated with TACE or RFA. They had undergone 18F-FDG PET/CT for evaluation of the therapeutic effect after the end of the therapy. Results:our study demonstrated that 18F-FDG PET/CT is a significant prognostic factor for tumor recurrence in post-therapeutic HCC with a cutoff TSUVmax/LSUVmax value of 1.3. Conclusion: 18F-FDG PET/CT imaging have a prognostic significance in evaluation of patients with post-therapeutic HCC and provide valuable information that can be used in the treatment response evaluation and clinical decision making process. | ||||
| Keywords | ||||
| FDG; PET; PET/CT; post-therapeutic; HCC; Hepatocellular carcinoma | ||||
|
Statistics Article View: 139 PDF Download: 215 |
||||
